SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFlowtech Fluid. Regulatory News (FLO)

Share Price Information for Flowtech Fluid. (FLO)

Share Price is delayed by 15 minutes
Get Live Data
54.60    -1.40 (-2.50%)
Bid:
52.60
Ask:
56.60
Spread: 4.00 (7.605%)
Market Cap: £45.60m
FLO Live PriceLast checked at - London Stock Exchange

Intraday Flowtech Fluid. Share Chart

Offer Update

12 Jun 2008 12:01

RNS Number : 5700W
Flomerics Group PLC
12 June 2008
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN

12 June 2008

Flomerics Group plc  (the "Company")

Continued Discussions

Further to the previously announced ongoing discussions with Autodesk, Inc. ("Autodesk") and pursuant to the requirements of the City Code on Takeovers and Mergers, the Company has been informed that should any offer be forthcoming from Autodesk, the consideration for such would be satisfied solely in cash.

As has been previously announced, at this stage there can be no certainty that an offer from Autodesk will be forthcoming, nor in the event of such, as to the terms on which any such offer might be made. 

This announcement has been made with the consent of Autodesk.

 

Enquiries:

Flomerics Group PLC

Gary Carter

Keith Butcher

Tel: 020 8487 3000

Jefferies International Ltd

Andres Pieczanski

Sarah McNicholas

Tel: 020 7029 8000

Oriel Securities Ltd

Andrew Edwards

Michael Shaw

Tel: 020 7710 7600

Citigate Dewe Rogerson

Ginny Pulbrook

Seb Hoyle

Tel: 020 7638 9571

  Flomerics Shares in Issue

Pursuant to Rule 2.10 of the City Code, Flomerics confirms that it has 22,935,250 ordinary shares of one penny each in issue and admitted to trading on the Alternative Investment Market of the London Stock Exchange (ISIN GB0003436192).

Dealing Disclosure Requirements

Under the provisions of Rule 8.3 of the Takeover Code (the 'Code'), if any person is, or becomes, 'interested' (directly or indirectly) in 1% or more of any class of 'relevant securities' of Flomerics, all 'dealings' in any 'relevant securities' of that company (including by means of an option in respect of, or a derivative referenced to, any such 'relevant securities') must be publicly disclosed by no later than 3.30 pm (London time) on the London business day following the date of the relevant transaction. This requirement will continue until the date on which the offer becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the 'offer period' otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an 'interest' in 'relevant securities' of Flomerics, they will be deemed to be a single person for the purpose of Rule 8.3.

Under the provisions of Rule 8.1 of the Code, all 'dealings' in 'relevant securities' of Flomerics by a potential offeror or by Flomerics, or by any of their respective 'associates', must be disclosed by no later than 12.00 noon (London time) on the London business day following the date of the relevant transaction.

A disclosure table, giving details of the companies in whose 'relevant securities' 'dealings' should be disclosed, and the number of such securities in issue, can be found on the Takeover Panel's website at www.thetakeoverpanel.org.uk.

'Interests in securities' arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an 'interest' by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities.

Terms in quotation marks are defined in the Code, which can also be found on the Panel's website. If you are in any doubt as to whether or not you are required to disclose a 'dealing' under Rule 8, you should consult the Panel.

Other

Jefferies International Limited, which is authorised and regulated in the UK by The Financial Services Authority, is acting exclusively for Flomerics and no one else in connection with the Mentor Offer and, accordingly, will not be responsible to anyone other than Flomerics for providing the protections afforded to customers of Jefferies International Limited or for providing advice in relation to the Mentor Offer or in relation to the contents of this document or any transaction or arrangement or other matter referred to herein.

Oriel Securities Limited ('Oriel Securities'), which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting for Flomerics and no-one else in connection with the matters referred to herein and will not be responsible to anyone other than Flomerics for providing the protections afforded to clients of Oriel Securities or for giving advice in relation to such matters.

Note to Editors

Flomerics (www.flomerics.com) is a world-leading developer of engineering simulation software and services for analysis of fluid flow, heat transfer. Flomerics' business model is drastically different from traditional analysis because its software is designed to be embedded deeply into the design process and used by mainstream design engineers, not just by analysis specialists.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OUPUURARWRRNAAR
Date   Source Headline
6th Jul 201510:24 amRNSHolding(s) in Company
6th Jul 201510:22 amRNSHolding(s) in Company
6th Jul 20157:00 amRNSAcquisition and Trading Update
4th Jun 20154:01 pmRNSHolding(s) in Company
27th May 20152:30 pmRNSHolding(s) in Company
21st May 20153:37 pmRNSResult of AGM
21st May 20157:00 amRNSAGM and Trading update
19th May 20157:00 amRNSHolding(s) in Company
29th Apr 20157:00 amRNSAnnual Financial Report
21st Apr 20155:25 pmRNSHolding(s) in Company
21st Apr 20154:07 pmRNSHolding(s) in Company
21st Apr 20159:54 amRNSHolding(s) in Company
15th Apr 20156:25 pmRNSHolding(s) in Company
14th Apr 20157:00 amRNSFinal Results
12th Mar 20152:14 pmRNSHolding(s) in Company
10th Feb 20151:48 pmRNSHolding(s) in Company
19th Jan 20157:00 amRNSTrading Update
15th Jan 201511:24 amRNSHolding(s) in Company
24th Oct 20145:03 pmRNSHolding(s) in Company
16th Sep 20147:00 amRNSInterim Report - six months ended 30 June 2014
26th Aug 20145:21 pmRNSHolding(s) in Company
26th Aug 201412:47 pmRNSHolding(s) in Company
18th Aug 20143:49 pmRNSHoldings in Company
13th Aug 201411:19 amRNSHolding(s) in Company
11th Aug 20144:03 pmRNSHolding(s) in Company
8th Aug 20148:00 amRNSTotal Voting Rights
7th Aug 201410:43 amRNSHolding(s) in Company
6th Aug 20145:02 pmRNSHolding(s) in Company
6th Aug 20141:08 pmRNSHolding(s) in Company
5th Aug 20147:00 amRNSAcquisition of Primary Fluid Holdings Limited
3rd Jul 20143:47 pmRNSHolding(s) in Company
18th Jun 20147:00 amRNSHolding(s) in Company (Hargreave Hale)
10th Jun 20144:41 pmRNSHolding(s) in Company (Hargreave Hale)
5th Jun 20144:45 pmRNSHolding(s) in Company (Hargreave Hale)
4th Jun 20144:29 pmRNSHolding(s) in Company (Miton Group plc)
28th May 20141:59 pmRNSHolding(s) in Company (Hargreave Hale)
23rd May 20141:53 pmRNSHolding(s) in Company (BlackRock Inv Mgt (UK) Ltd)
23rd May 20141:50 pmRNSHolding(s) in Company (Diverse Income Trust Plc)
23rd May 20141:48 pmRNSHolding(s) in Company (River & Mercantile AM LLP)
23rd May 20141:46 pmRNSHolding(s) in Company (Standard Life Investments)
23rd May 201412:12 pmRNSHolding(s) in Company (Schroder Inv Mgt)
23rd May 201412:07 pmRNSHolding(s) in Company (Hargreave Hale)
22nd May 20147:00 amRNSHolding(s) in Company (Premier Fund Managers)
21st May 20147:01 amRNSFlowtech Fluidpower plc - NED appointments
21st May 20147:00 amRNSAIM Admission & First day of dealings
26th Aug 200811:37 amRNSCancellation of Listing
8th Aug 20084:51 pmRNSDirectorate Change
6th Aug 20087:00 amRNSDirectorate Change
29th Jul 20087:00 amRNSDelisting and Compulsory Acqu
11th Jul 200810:43 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.